Genetically Engineered Mouse Models in Preclinical Anti-Cancer Drug Development

QR Code

Genetically Engineered Mouse Models in Preclinical Anti-Cancer Drug Development

None

Saved in:

Bibliographic Details
Main Authors:	Alcoser, Sergio Y., Hollingshead, Melinda G.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

From Basic Research to Clinical Trials: Preclinical Trial Evaluation in Mouse Models
by: Bogdanovich, Sasha, et al.
Published: (2012)

Genetic Mouse Models for Osteoarthritis Research
by: Shen, Jie, et al.
Published: (2012)

Oncolytic Poliovirus Therapy in a Mouse Model of Neuroblastoma: Preclinical Data Analysis and Future Studies
by: Toyoda, Hidemi, et al.
Published: (2012)

Mouse Models of Experimental Atherosclerosis as a Tool for Checking a Putative Anti-Atherogenic Action of Drugs
by: Jawien, Jacek
Published: (2012)

Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies
by: Zane Kalniņa, et al.
Published: (2025-08-01)

Animal Models for Basic and Preclinical Research in Bladder Cancer
by: Eiján, Ana María, et al.
Published: (2012)

Use of Animal Models for Anti-HIV Drug Development
by: Ambrose, Zandrea
Published: (2012)

Mouse Models for Atopic Dermatitis Developed in Japan
by: Yonekawa, Hiromichi, et al.
Published: (2012)

Prostate and Colon Cancer Stem Cells as a Target for Anti-Cancer Drug Development
by: Botchkina, Galina, et al.
Published: (2011)

Mouse Models of Depression
by: Dedic, Nina, et al.
Published: (2011)

Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies
by: O, A. Bezborodova, et al.
Published: (2020-06-01)

Preclinical and Clinical Developments in Molecular Targeting Therapeutic Strategies for Breast Cancer
by: Fujii, Teruhiko, et al.
Published: (2011)

Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model
by: Shibata, Masa-Aki, et al.
Published: (2011)

Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models
by: Seungyeon Ryu, et al.
Published: (2025-06-01)

Non-Steroidal Anti-Inflammatory Drugs, DNA Repair and Cancer
by: Dibra, Harpreet K., et al.
Published: (2011)

Mouse Models of Human Familial Paraganglioma
by: III, Louis J. Maher, et al.
Published: (2011)

Mouse Models of Chronic Lymphocytic Leukemia
by: Pérez-Chacón, Gema, et al.
Published: (2012)

Effect and mechanism of HER2 antibody-drug conjugate combined with anti-PD-1 antibody in mouse bladder cancer models
by: HE Shuo, et al.
Published: (2025-07-01)

Mouse Models of Testicular Germ Cell Tumors
by: Carouge, Delphine, et al.
Published: (2012)

The Development of Encephalitis Following Tick-Borne Encephalitis Virus Infection in a Mouse Model
by: Hayasaka, Daisuke
Published: (2011)

Chromosome Engineering in Mouse Embryonic Stem Cells: Addition and Elimination of Targeted Chromosomes
by: Tada, Masako
Published: (2011)

Preclinical study of reirradiation with hyperthermia in recurrent murine tumors and normal mouse skin
by: Charlemagne A Folefac, et al.
Published: (2025-07-01)

Mouse B cells engineered to express an anti-HPV antibody elicit anti-tumor T cell responses
by: Michal Guberman Bracha, et al.
Published: (2025-07-01)

State of the Art of Anti-Inflammatory Drugs
by: Souza, Túlio Ricardo Couto de Lima, et al.
Published: (2012)

Medication Development for the Treatment of Cocaine Addiction – Progress at Preclinical and Clinical Levels
by: Xi, Zheng-Xiong
Published: (2012)

Genetic Variation in Drug Disposition
by: Regmi, Balmukunda, et al.
Published: (2012)

Preclinical Solutions for Insight in Premotor Parkinson
by: Philippens, Ingrid H.C.H.M., et al.
Published: (2011)

Genetic Variation in AhR Gene Related to Dioxin Sensitivity in the Japanese Field Mouse, Apodemus speciosus
by: Ishiniwa, Hiroko, et al.
Published: (2012)

Pharmacogenetics for T2DM and Anti-Diabetic Drugs
by: Huang, Qiong, et al.
Published: (2011)

Possibility of using a mouse SCID as a model animal to variola virus for evaluating anti-smallpox drug efficacy
by: K. A. Titova, et al.
Published: (2015-12-01)

BCC and the Secret Lives of Patched: Insights from Patched Mouse Models
by: Li, Zhu Juan, et al.
Published: (2012)

From Mouse to Man: Translational Value of Animal Models of Allergic Rhinitis
by: Wagner, James G., et al.
Published: (2012)

Combination Chemotherapy in Cancer: Principles, Evaluation and Drug Delivery Strategies
by: Pinto, Ana Catarina, et al.
Published: (2011)

Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids
by: Giulia Agostini, et al.
Published: (2025-07-01)

Preclinical in vivo Neurotoxicity Studies of Drug Candidates
by: N. V. Eremina, et al.
Published: (2020-09-01)

Tumor neoantigens as key drivers of significant anti - tumor immunity in triple - negative breast cancer mouse models
by: Yujeong Her, et al.
Published: (2025-09-01)

Deficiency of Adult Neurogenesis in the Ts65Dn Mouse Model of Down Syndrome
by: Belichenko, Pavel V., et al.
Published: (2011)

Proteomic Analysis of Mouse ES Cells
by: Kurisaki, Akira, et al.
Published: (2011)

Flaky Tail Mouse as a Novel Animal Model of Atopic Dermatitis: Possible Roles of Filaggrin in the Development of Atopic Dermatitis
by: Moniaga, Catharina Sagita, et al.
Published: (2012)

Preclinical and Clinical Prospects of Gene Therapy in Myocardial Infarction
by: Bharti, Saurabh, et al.
Published: (2011)